Lupin's Q3 Net Profit Jumps 38% Driven by Strong US Sales and Divestment Benefits

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Lupin Q3 Net Profit Jumps 38% on Strong US Sales, Divestment Gains

Lupin said the US drug regulator has classified its inspection of the Pithampur Unit 2 manufacturing facility as 'official action indicated' (OAI).

The US Food and Drug Administration (USFDA) had conducted inspections at the facility from July 8 to July 17, 2025, and closed it by issuing Form 483 with four observations.

C

CNBC TV18•12-02-2026, 23:44

Lupin Q3 Net Profit Jumps 38% on Strong US Sales, Divestment Gains

•Lupin reported a consolidated net profit of ₹1,175.6 crore in Q3 FY26, a 37.5% increase year-on-year.
•Consolidated revenue from operations reached ₹7,167.5 crore, up 24.3% year-on-year.
•US sales surged by 54% to ₹3,113.2 crore, contributing 44% to global sales.
•Gains from divestment of OTC and API R&D businesses totaled ₹658.9 crore and ₹3.7 crore respectively.
•The company launched three products in the US and three brands in India during the quarter.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Lumax Auto Tech | Among the nine names highlighted by SBI Securities, Lumax Auto Tech has the highest potential upside. The brokerage has a price target of ₹854 on the stock, which implies a potential upside of 51% from current levels.

Lumax Shares Soar 20% to 52-Week High on Robust Q3 Earnings

Lumax Industries का स्टॉक 20% बढ़कर 6,136.30 रुपये पर बंद हुआ।

Lumax Industries Shares Soar 20% on Robust Q3 Earnings, Hits 52-Week High

Lupin, Lupin share price, Lupin stock, Lupin shares, Lupin 52 week high, Lupin shares hit 52 week high, Lupin shares gain, Lupin guidance, Lupin target,

Lupin Shares Soar to 52-Week High on Strong Q3, Biosimilar Pipeline

Lupin Raises FY26 Margin Guidance to 27-28% Amid Strong Growth

Lupin Raises FY26 Margin Guidance to 27-28% Amid Strong Growth

With the third quarter earnings season drawing to a close, there will be a beeline of companies reporting their quarterly results in the upcoming week. A combination of Nifty 50 companies, F&O stocks, and new listings as well, will be part of the list for the week. Here's a look at some of the major earnings that you should have your eyes on:

Lumax Auto Technologies Q3 Profit Soars 83%, Revenue Jumps 40%

Lupin said the US drug regulator has classified its inspection of the Pithampur Unit 2 manufacturing facility as 'official action indicated' (OAI).

The US Food and Drug Administration (USFDA) had conducted inspections at the facility from July 8 to July 17, 2025, and closed it by issuing Form 483 with four observations.

Lupin's Ankleshwar Facility Gets 2 US FDA Observations; Q3 Profit Up 37.5%